{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:32:45Z","timestamp":1793417565832,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.molmed.2021.04.004","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T16:33:23Z","timestamp":1620491603000},"page":"673-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Amer","family":"Jamalpoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1074","authenticated-orcid":false,"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoe J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2021.04.004_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000495270","article-title":"Molecular basis of cystinosis: geographic distribution, functional consequences of mutations in the CTNS gene, and potential for repair","volume":"141","author":"David","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.molmed.2021.04.004_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00467-010-1627-6","article-title":"Cystinosis: practical tools for diagnosis and treatment","volume":"26","author":"Wilmer","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fped.2018.00058","article-title":"Nephropathic cystinosis: symptoms, treatment, and perspectives of a systemic disease","volume":"6","author":"Baumner","year":"2018","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.molmed.2021.04.004_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2215\/CJN.01740407","article-title":"Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping","volume":"3","author":"Servais","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drudis.2013.02.003","article-title":"Cysteamine: an old drug with new potential","volume":"18","author":"Besouw","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2021.04.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13572","article-title":"Trends in kidney transplant outcomes in children and young adults with cystinosis","volume":"23","author":"Kizilbash","year":"2019","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.molmed.2021.04.004_bb0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbadis.2011.02.010","article-title":"Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells","volume":"1812","author":"Wilmer","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2021.04.004_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymgme.2013.01.014","article-title":"In vitro correction of disorders of lysosomal transport by microvesicles derived from baculovirus-infected Spodoptera cells","volume":"109","author":"Thoene","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2021.04.004_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneph.2016.182","article-title":"The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives","volume":"13","author":"Cherqui","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1681\/ASN.2013060598","article-title":"Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys","volume":"25","author":"Gaide Chevronnay","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0055","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1073\/pnas.1115581109","article-title":"Mechanism of proton\/substrate coupling in the heptahelical lysosomal transporter cystinosin","volume":"109","author":"Ruivo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.004_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbrc.2011.03.022","article-title":"Reduced phosphate transport in the renal proximal tubule cells in cystinosis is due to decreased expression of transporters rather than an energy defect","volume":"407","author":"Taub","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2021.04.004_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1203\/PDR.0b013e318183fd67","article-title":"Mitochondrial complex V expression and activity in cystinotic fibroblasts","volume":"64","author":"Wilmer","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.molmed.2021.04.004_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1203\/01.pdr.0000196334.46940.54","article-title":"Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts","volume":"59","author":"Levtchenko","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.molmed.2021.04.004_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1681\/ASN.2009040383","article-title":"Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis","volume":"21","author":"Sansanwal","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0080","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1007\/s00018-018-2800-5","article-title":"Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis","volume":"75","author":"Bellomo","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bbrc.2012.08.115","article-title":"Activation of AMP kinase plays a role in the increased apoptosis in the renal proximal tubule in cystinosis","volume":"426","author":"Taub","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2021.04.004_bb0090","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2021.04.004_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/antiox7120179","article-title":"The role of cystinosin in the intermediary thiol metabolism and redox homeostasis in kidney proximal tubular cells","volume":"7","author":"Sumayao","year":"2018","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.molmed.2021.04.004_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbrc.2004.09.033","article-title":"Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines","volume":"324","author":"Chol","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2021.04.004_bb0105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.freeradbiomed.2010.01.011","article-title":"Modulation of CTNS gene expression by intracellular thiols","volume":"48","author":"Bellomo","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molmed.2021.04.004_bb0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1203\/01.pdr.0000196370.57200.da","article-title":"Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts","volume":"59","author":"Mannucci","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.molmed.2021.04.004_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2005.09.094","article-title":"Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells","volume":"337","author":"Wilmer","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2021.04.004_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41467-017-02536-7","article-title":"Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney","volume":"9","author":"Festa","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/15548627.2018.1446625","article-title":"Defective autophagy degradation and abnormal tight junction-associated signaling drive epithelial dysfunction in cystinosis","volume":"14","author":"Luciani","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2021.04.004_bb0130","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/hmg\/ddt617","article-title":"Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis","volume":"23","author":"Raggi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0135","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2019040371","article-title":"Protection of cystinotic mice by kidney-specific megalin ablation supports an endocytosis-based mechanism for nephropathic cystinosis progression","volume":"30","author":"Janssens","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0140","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/01.ASN.0000036867.49866.59","article-title":"Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells","volume":"13","author":"Park","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0145","doi-asserted-by":"crossref","first-page":"42583","DOI":"10.1038\/srep42583","article-title":"Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction","volume":"7","author":"Elmonem","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.04.004_bb0150","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1681\/ASN.2006050474","article-title":"Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase C\u03b4","volume":"17","author":"Park","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00467-009-1289-4","article-title":"Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis","volume":"25","author":"Sansanwal","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0160","doi-asserted-by":"crossref","first-page":"F1155","DOI":"10.1152\/ajprenal.00591.2014","article-title":"The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis","volume":"308","author":"Galarreta","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00467-004-1712-9","article-title":"Potential role of apoptosis in development of the cystinotic phenotype","volume":"20","author":"Park","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ymgme.2007.07.008","article-title":"A review of the role of enhanced apoptosis in the pathophysiology of cystinosis","volume":"92","author":"Thoene","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2021.04.004_bb0175","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1681\/ASN.2019070712","article-title":"Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine\/mTOR inhibition combination therapy for cystinosis","volume":"31","author":"Hollywood","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0180","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.1193497","article-title":"Autophagy and metabolism","volume":"330","author":"Rabinowitz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.004_bb0185","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1681\/ASN.2014090937","article-title":"Cystinosin is a component of the vacuolar H+-ATPase-Ragulator-Rag complex controlling mammalian target of rapamycin complex 1 signaling","volume":"27","author":"Andrzejewska","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10545-016-9919-z","article-title":"Altered mTOR signalling in nephropathic cystinosis","volume":"39","author":"Ivanova","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2021.04.004_bb0195","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/cdd.2017.133","article-title":"Atg2A\/B deficiency switches cytoprotective autophagy to non-canonical caspase-8 activation and apoptosis","volume":"24","author":"Tang","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2021.04.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120998","article-title":"Endo-lysosomal dysfunction in human proximal tubular epithelial cells deficient for lysosomal cystine transporter cystinosin","volume":"10","author":"Ivanova","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2021.04.004_bb0205","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1681\/ASN.2012050476","article-title":"Rheb\/mTORC1 signaling promotes kidney fibroblast activation and fibrosis","volume":"24","author":"Jiang","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2010.457","article-title":"mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression","volume":"79","author":"Huber","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2021.04.004_bb0215","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2021.04.004_bb0220","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1242\/jcs.158550","article-title":"The vacuolar-type H+-ATPase at a glance\u2014more than a proton pump","volume":"127","author":"Maxson","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2012.07.032","article-title":"Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1","volume":"150","author":"Bar-Peled","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.004_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.15252\/emmm.201404223","article-title":"Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis","volume":"7","author":"Napolitano","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2021.04.004_bb0235","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/15548627.2015.1058475","article-title":"The symphony of autophagy and calcium signaling","volume":"11","author":"Yao","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2021.04.004_bb0240","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.kint.2015.12.045","article-title":"Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells","volume":"89","author":"Rega","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2021.04.004_bb0245","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"Lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0250","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00467-012-2227-4","article-title":"p62\/SQSTM1 prominently accumulates in renal proximal tubules in nephropathic cystinosis","volume":"27","author":"Sansanwal","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tcb.2012.05.006","article-title":"Chaperone-mediated autophagy: a unique way to enter the lysosome world","volume":"22","author":"Kaushik","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0260","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1091\/mbc.e04-06-0477","article-title":"Activation of chaperone-mediated autophagy during oxidative stress","volume":"15","author":"Kiffin","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2021.04.004_bb0265","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1074\/jbc.M116.764076","article-title":"Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A","volume":"292","author":"Zhang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.004_bb0270","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/MCB.00417-13","article-title":"Upregulation of the Rab27a-dependent trafficking and secretory mechanisms improves lysosomal transport, alleviates endoplasmic reticulum stress, and reduces lysosome overload in cystinosis","volume":"33","author":"Johnson","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0275","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0280","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1681\/ASN.2013060653","article-title":"Inflammasome activation by cystine crystals: implications for the pathogenesis of cystinosis","volume":"25","author":"Prencipe","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-014-0155-z","article-title":"Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis","volume":"9","author":"Elmonem","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.molmed.2021.04.004_bb0290","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.kint.2019.01.029","article-title":"Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis","volume":"96","author":"Lobry","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2021.04.004_bb0295","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0002-9440(10)64595-6","article-title":"Up-regulation of galectin-3 in acute renal failure of the rat","volume":"157","author":"Nishiyama","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0300","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.devcel.2019.10.025","article-title":"Galectin-3 coordinates a cellular system for lysosomal repair and removal","volume":"52","author":"Jia","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2021.04.004_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12325-018-0661-9","article-title":"A Phase 1 pharmacokinetic study of cysteamine bitartrate delayed-release capsules following oral administration with orange juice, water, or omeprazole in cystinosis","volume":"35","author":"Armas","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.molmed.2021.04.004_bb0315","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1080\/03007995.2017.1354288","article-title":"A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis","volume":"33","author":"Medic","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.molmed.2021.04.004_bb0320","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2014.05.013","article-title":"Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate","volume":"165","author":"Langman","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.molmed.2021.04.004_bb0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00467-012-2315-5","article-title":"Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up","volume":"28","author":"Dohil","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0330","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.12321211","article-title":"A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety","volume":"7","author":"Langman","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carres.2016.12.003","article-title":"Evaluation of carbohydrate-cysteamine thiazolidines as pro-drugs for the treatment of cystinosis","volume":"439","author":"Ramazani","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.molmed.2021.04.004_bb0340","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2015.12.027","article-title":"Synthesis of diacylated gamma-glutamyl-cysteamine prodrugs, and in vitro evaluation of their cytotoxicity and intracellular delivery of cysteamine","volume":"109","author":"Frost","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2021.04.004_bb0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bmcl.2010.11.085","article-title":"PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis","volume":"21","author":"Omran","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2021.04.004_bb0350","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bmcl.2011.02.048","article-title":"Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis","volume":"21","author":"Omran","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2021.04.004_bb0355","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.bmc.2011.04.022","article-title":"Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis","volume":"19","author":"Omran","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molmed.2021.04.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154805","article-title":"Carboxyl-terminal SSLKG motif of the human cystinosin-LKG plays an important role in plasma membrane sorting","volume":"11","author":"Bellomo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2021.04.004_bb0365","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1681\/ASN.2019090956","article-title":"Cell-based phenotypic drug screening identifies luteolin as candidate therapeutic for nephropathic cystinosis","volume":"31","author":"De Leo","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0370","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13667","article-title":"The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue","volume":"6","author":"Gottwald","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.molmed.2021.04.004_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","article-title":"Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs)","volume":"30","author":"Nagel-Wolfrum","year":"2016","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2021.04.004_bb0380","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-018-4173-2","article-title":"A breakthrough in readthrough? Could geneticin lead the way to effective treatment for cystinosis nonsense mutations?","volume":"34","author":"Midgley","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0385","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00467-018-4094-0","article-title":"The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis","volume":"34","author":"Brasell","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0395","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3390\/ijms20133329","article-title":"Strategies against nonsense: oxadiazoles as translational readthrough-inducing drugs (TRIDs)","volume":"20","author":"Campofelice","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223954","article-title":"The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis","volume":"14","author":"Brasell","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2021.04.004_bb0405","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00467-018-3974-7","article-title":"Potential use of stem cells as a therapy for cystinosis","volume":"34","author":"Rocca","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0410","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2009-03-213934","article-title":"Successful treatment of the murine model of cystinosis using bone marrow cell transplantation","volume":"114","author":"Syres","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2021.04.004_bb0415","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/ndt\/gft270","article-title":"Is genetic rescue of cystinosis an achievable treatment goal?","volume":"29","author":"Cherqui","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2021.04.004_bb0420","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ki.2010.537","article-title":"Kidney preservation by bone marrow cell transplantation in hereditary nephropathy","volume":"79","author":"Yeagy","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2021.04.004_bb0425","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.juro.2010.03.050","article-title":"Therapeutic applications of mesenchymal stem cells to repair kidney injury","volume":"184","author":"Asanuma","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042840","article-title":"Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro","volume":"7","author":"Iglesias","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2021.04.004_bb0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/mt.2012.214","article-title":"Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis","volume":"21","author":"Harrison","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2021.04.004_bb0440","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/stem.1835","article-title":"Brief reports: lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes","volume":"33","author":"Naphade","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2021.04.004_bb0445","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1167\/iovs.15-17107","article-title":"Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation","volume":"56","author":"Rocca","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molmed.2021.04.004_bb0450","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/en.2015-1762","article-title":"Hematopoietic stem cells transplantation can normalize thyroid function in a cystinosis mouse model","volume":"157","author":"Gaide Chevronnay","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2021.04.004_bb0455","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/mt.2008.126","article-title":"Gene transfer may be preventive but not curative for a lysosomal transport disorder","volume":"16","author":"Hippert","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2021.04.004_bb0460","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/ajt.15029","article-title":"Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: first human report","volume":"18","author":"Elmonem","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.molmed.2021.04.004_bb0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41431-019-0521-3","article-title":"Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis","volume":"28","author":"Fleige","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0470","first-page":"100514","article-title":"Molecular based newborn screening in Germany: follow-up for cystinosis","volume":"21","author":"Hohenfellner","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.molmed.2021.04.004_bb0475","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","article-title":"Estimating prevalence in single-gene kidney diseases progressing to renal failure","volume":"58","author":"Levy","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2021.04.004_bb0480","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jmg.13.6.434","article-title":"Infantile cystinosis in France: genetics, incidence, geographic distribution","volume":"13","author":"Bois","year":"1976","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0485","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000153992","article-title":"Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada)","volume":"41","author":"De Braekeleer","year":"1991","journal-title":"Hum. Hered."},{"key":"10.1016\/j.molmed.2021.04.004_bb0490","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.molmed.2021.04.004_bb0495","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12098-015-2014-x","article-title":"Lysosomal storage disorders in Egyptian children","volume":"83","author":"Elmonem","year":"2016","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.molmed.2021.04.004_bb0500","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jmg.2010.083303","article-title":"The 57 kb deletion in cystinosis patients extends into TRPV1 causing dysregulation of transcription in peripheral blood mononuclear cells","volume":"48","author":"Freed","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0505","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nefro.2015.09.009","article-title":"Molecular analysis of the CTNS gene in Jordanian families with nephropathic cystinosis","volume":"35","author":"Jaradat","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/j.molmed.2021.04.004_bb0510","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/302118","article-title":"CTNS mutations in an American-based population of cystinosis patients","volume":"63","author":"Shotelersuk","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0515","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/hmg\/8.13.2507","article-title":"Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin","volume":"8","author":"Attard","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.004_bb0520","first-page":"63","article-title":"CTNS mutations in publicly-available human cystinosis cell lines","volume":"5","author":"Zykovich","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.molmed.2021.04.004_bb0525","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2160763X12454423","article-title":"The effect of food on cysteamine bitartrate absorption in healthy participants","volume":"1","author":"Dohil","year":"2012","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.molmed.2021.04.004_bb0530","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/bjophthalmol-2016-309278","article-title":"Efficacy of topical cysteamine in nephropathic cystinosis","volume":"101","author":"Al-Hemidan","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.molmed.2021.04.004_bb0535","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/bioinformatics\/btt607","article-title":"Protter: interactive protein feature visualization and integration with experimental proteomic data","volume":"30","author":"Omasits","year":"2014","journal-title":"Bioinformatics"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142100099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142100099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:52:01Z","timestamp":1778615521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142100099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S147149142100099X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2021.04.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2021.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}